Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Harold H. Handley"'
Autor:
Vijay Kher, R. Paul Duffin, Puneet Sodhi, Harold H. Handley, James A. Joyce, Jeevan Menon, Richard H. Tullis
Publikováno v:
Blood Purification. 27:64-69
Background/Aims: To test the safety and efficacy of the Aethlon Hemopurifier®, a lectin affinity cartridge, in clearing hepatitis C virus (HCV) from the blood of HCV-positive end-stage renal disease patients undergoing dialysis. Viral RNA was measur
Publikováno v:
Journal of Autoimmunity. 8:659-673
A 65 kDa mycobacterial heat shock protein has been implicated in the development or perpetuation of the inflammatory diseases rheumatoid arthritis (RA) and insulin dependent diabetes mellitus (IDDM). An homology of the mycobacterial hsp65 with human
Publikováno v:
Journal of Reproductive Immunology. 20:205-220
Major rat sperm autoantigens of 86, 63, 43, 28 and 20 kDa are recognized by post-vasectomy and hyperimmunization antisera from the Lewis rat (Handley et al., Biol. Reprod. 39 (1988) 1239-1250). In the present study, affinity purified monospecific iso
Autor:
Harold H, Handley, Rey, Gorsuch, Harold, Peters, Thomas G, Cooper, Richard H, Bien, Nathan W, Levin, Claudio, Ronco
Publikováno v:
Contributions to nephrology. 149
An intravenous plasmapheresis catheter which excludes99.4% of platelets from external ultrafiltration circuits is currently undergoing safety and efficacy trials for fluid removal from NYHA class II-IV congestive heart failure patients resistant to d
Autor:
Richard H. Bien, Thomas G. Cooper, Nathan W. Levin, Harold W. Peters, Harold H. Handley, Rey Gorsuch, Claudio Ronco
An intravenous plasmapheresis catheter which excludes >99.4% of platelets from external ultrafiltration circuits is currently undergoing safety and efficacy trials for fluid removal from NYHA class
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bee6d466122aed9367d671dd446d137
https://doi.org/10.1159/000085695
https://doi.org/10.1159/000085695
Autor:
Harold H, Handley, Rey, Gorsuch, Harold, Peters, Lutgardo, Punzalan, Thomas G, Cooper, Nathan W, Levin, Claudio, Ronco
Publikováno v:
Contributions to nephrology. 142
Intermittent dialysis is still the predominant treatment for acute or chronic renal insufficiency in the USA despite increasing evidence that slower and longer fluid management therapies are more beneficial to the patient. We have investigated the us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1932638762c7b9901ce6f17ecb61139
http://hdl.handle.net/11577/3293799
http://hdl.handle.net/11577/3293799
Future advances in dialysis of end-stage renal disease patients may include improvements in therapeutic continuity and patient mobility. Continuous renal replacement therapies could lead to self-contained, mobile and potentially wearable dialysis uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4732473ac5046aff33ab9b8c041dd0b3
http://hdl.handle.net/11577/3293446
http://hdl.handle.net/11577/3293446
Publikováno v:
Clinical and experimental immunology. 103(3)
SUMMARY The 65-kD hsp from Mycobacterium tuberculosis has been reported to induce an autopathogenic subset of T cells in at least two animal models of autoimmune disease. Reports of increased expression of human hsp60 in the inflamed synovial tissue